Drug Delivery Predoctoral Fellowship
Drug Delivery Predoctoral Fellowship supports advanced doctoral students researching drug formulation, manufacturing, and delivery to make treatments safer, more effective, and clinically viable.
Browse similar grants
Funder: PhRMA Foundation
Due Dates: October 30, 2026, noon ET (Letter of intent) | Mid-February 2027 (Invitations) | March 2027 (Full application) | July 2027 (Award notification)
Funding Amounts: $30,000 per year in stipend support for 12, 18, or 24 months
Summary: Supports advanced doctoral students researching drug formulation, manufacturing, and delivery to improve treatment safety, effectiveness, and clinical viability.
Key Information: Only one applicant per lab per Drug Delivery funding cycle; labs must choose a predoctoral or postdoctoral applicant.
Description
The PhRMA Foundation’s Drug Delivery Predoctoral Fellowship supports students in advanced training and thesis research in basic pharmaceutics, biopharmaceutics, pharmaceutical technology, pharmaceutical biotechnology, and biomedical engineering. It funds therapeutically relevant research that optimizes drug composition, dosage, and delivery to make treatments clinically viable, safer, more effective, or easier for patients to manage.
Research may address formulations and delivery technologies that achieve desired pharmacokinetics and pharmacodynamics, manufacturing processes that improve product quality for challenging chemical entities, or predictive approaches connecting drug quality attributes with in vivo performance, efficacy, and toxicity. Research applicable to multiple drug modalities is prioritized. This opportunity is the Foundation’s second 2027 funding cycle, part of an expansion intended to support 500 early-career researchers over three years.
